BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1607914)

  • 21. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
    De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
    Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of adult acute lymphoblastic leukemia with Ad-VP-L regimen].
    Umeda M; Shikoshi K; Anno S; Su CY; Shirai T
    Rinsho Ketsueki; 1991 Jan; 32(1):6-10. PubMed ID: 2020119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.
    Ueda T; Miyawaki S; Asou N; Kuraishi Y; Hiraoka A; Kuriyama K; Minami S; Ohshima T; Ino T; Tamura J; Kanamaru A; Nishikawa K; Tanimoto M; Oh H; Saito K; Nagata K; Naoe T; Yamada O; Urasaki Y; Sakura T; Ohno R
    Int J Hematol; 1998 Oct; 68(3):279-89. PubMed ID: 9846012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma].
    Hu Y; Zhao X; Wu LL; Cai CP; Zhao WL; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):680-4. PubMed ID: 25286699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
    Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
    J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive retreatment of adults and children with acute lymphoblastic leukemia.
    Bassan R; Cornelli PE; Battista R; Terzi F; Buelli M; Rambaldi A; Viero P; D'Emilio A; Dini E; Barbui T
    Hematol Oncol; 1992; 10(2):105-10. PubMed ID: 1592360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Colović M; Bogdanović A; Janković G; Kraguljac N; Suvajdzić N
    Chemotherapy; 2003 Jun; 49(3):138-45. PubMed ID: 12815207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.
    Pinheiro Junior ED; Pracchia LF; Beitler de Mauriño B; Martinez GA; Dorlhiac-Llacer PE; Medina AB; Velloso ED
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e7-e14. PubMed ID: 25130688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase].
    Wernli M; Gratwohl A; von Fliedner V; Tichelli A; Clément F; Grob JP; Chapuis B; Maurice P; Brun del Re G; Fey MF
    Schweiz Med Wochenschr; 1991 Feb; 121(6):194-8. PubMed ID: 2008599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG).
    Tanimoto M; Miyawaki S; Ino T; Kyo T; Sakamaki H; Naoe T; Hiraoka A; Asou N; Ohshima T; Tsubaki K; Kuriyama K; Ueda T; Minamil S; Okabe K; Saito H; Murakami H; Hirano M; Dohy H; Onozawa Y; Suzuki H; Ohno R
    Int J Hematol; 1998 Dec; 68(4):421-9. PubMed ID: 9885441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.
    Dudler C; Bargetzi M; Tichelli A; Gratwohl A; Passweg JR; Wernli M
    Eur J Haematol; 2009 Dec; 83(6):512-8. PubMed ID: 19614953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
    Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
    Wang J; Huang XJ; Jiang B; Jiang Q; Lu XJ; Xu LP; Liu DH; Chen H; Bao L; Lu J; Zhu HH; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):938-44. PubMed ID: 24343078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of lymphoblastic lymphoma in adults.
    Coleman CN; Picozzi VJ; Cox RS; McWhirter K; Weiss LM; Cohen JR; Yu KP; Rosenberg SA
    J Clin Oncol; 1986 Nov; 4(11):1628-37. PubMed ID: 3772416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian HM; O'Brien S; Smith TL; Cortes J; Giles FJ; Beran M; Pierce S; Huh Y; Andreeff M; Koller C; Ha CS; Keating MJ; Murphy S; Freireich EJ
    J Clin Oncol; 2000 Feb; 18(3):547-61. PubMed ID: 10653870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors analysis for R-CHOP regimen therapy in diffuse large B cell lymphoma].
    Shen Y; Yao Y; Li JM; Chen QS; You JH; Zhao HJ; Chen S; Shen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):252-7. PubMed ID: 18843980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.